Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
Aim of investigation. To estimate efficacy of rifaximin in complex conservative treatment of chronic diverticulitis.Material and methods. The main group included 43 patients that received 200 mg rifaximin every 8 h within conservative treatment mode for 14 days. Of all patients 34 were women (79,1%)...
Saved in:
Main Authors: | S. I. Achkasov, A. I. Moskalyov, Yu. L. Trubachyova, A. F. Filon |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2012-04-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1282 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclic rifaximin therapy effectively prevents
the recurrence of symptoms after exacerbation
of symptomatic uncomplicated diverticular disease: a retrospective study
by: Anna M. Pietrzak, et al.
Published: (2019-03-01) -
Results of surgical treatment of patients with acute destructive diverticulitis of the colon using minimally invasive technologies
by: O.B. Tymchuk, et al.
Published: (2024-06-01) -
Comprehensive Ultrasound Diagnosis of Sigmoid Diverticulitis
by: A. I. Кoushnerou, et al.
Published: (2021-12-01) -
Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01) -
The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
by: Andrzej Moniuszko, et al.
Published: (2017-06-01)